HATBORO, Pa., Feb. 15, 2024 /PRNewswire/ — There are currently more than 3,000 advanced therapies in the development pipeline globally, along with 124 approved therapies. To enable this innovation and transformation of therapeutic options, Azzur Group today announces the introduction of analytical laboratory testing services for advanced therapeutic medicinal products (ATMPs).
The capabilities and expertise are built upon a foundation of safety, quality, and product stability to meet stringent regulatory requirements.
“When developing advanced therapeutics for patients, speed and compliance are critical. Expertise and time dedicated to method development, quality control testing, and validating analytical procedures are fundamental to success,” said Jorge Marques Signes, PhD, Vice President of Advanced Therapies Services. “The Azzur team is excited to enable industry pioneers in the delivery of novel cell and gene therapies that continue to not only change the course of medicine as we know it, but greatly enhance the lives of the patients who need it the most.”
With the introduction of advanced therapeutics testing services, Azzur Group has developed a new platform model that addresses the manufacturing infrastructure, processes, and application of expertise tailored to the specific demands of the pipeline lifecycle: fit-for-purpose and fit-for-phase, cost-effective, value-adding infrastructure support and scientific expertise. This solution includes Azzur Cleanrooms on Demand™, which combines manufacturing infrastructure, compliance expertise, and training without the burden of facility ownership. Azzur’s full suite of services provides a unique, unconstrained, and phase-appropriate GMP solution for cell and gene therapy development and manufacturing.
Azzur Group’s ATMP Analytical Services include assay and protocol development (compendial and non-compendial), study design and execution, and analytical/bioanalytical testing. For a full list of services and testing, visit Azzur.com/ATMP.
“It is our mission at Azzur Group to lead the charge in innovative solutions that enable our customers to progress science and innovation safely, compliantly, and efficiently,” said Sarah Stevens, PhD, President, Azzur Labs and Azzur Cleanrooms on Demand™. “The comprehensive Azzur approach to advanced therapeutics offers clients a model of speed and adaptability that will revolutionize manufacturing flexibility in the industry.”
For more information, visit Azzur.com.
About Azzur Group
From Discovery to Delivery™, Azzur Group provides the life science community full life-cycle solutions for all their GxP needs. From Azzur Cleanrooms on Demand™ facilities, to our labs, training centers and consulting offices across the nation, Azzur Group helps organizations start, scale, and sustain their growing enterprises. With nearly four decades of service to the life science community, we have become a trusted partner to the world’s leading pharmaceutical, biotechnology, medical device, and healthcare companies, as well as their supply chain. Follow us on LinkedIn. For more information, visit Azzur.com.
CONTACT: Katie Brown, katie.brown@azzur.com
SOURCE Azzur Group, LLC
Black Book outlines an AI-era integrity architecture for healthcare benchmarking, instrumentation hardening, tiered verification, real-time…
Bagsværd, Denmark, 31 January 2026 – Thomas Rantzau, employee representative on the Board of Directors since…
Baltimore, Maryland, Jan. 31, 2026 (GLOBE NEWSWIRE) -- After sustaining water damage during the massive…
Science-Backed Spermidine Ritual Brings Cellular Renewal to a High-Performance Cultural Moment Primeadine Longevity Shot Primeadine…
CRANFORD, N.J., Jan. 30, 2026 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (OTCQB: ENZN) (“Enzon” or…
MINNEAPOLIS, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Park Dental Partners, Inc. (NASDAQ: PARK), a leading…